Jan 23, 2020 2:48 AM
BACK TO TOP
KSE 100
42,561.27
-65.20
(-0.15%)
KSE ALL
29,561.63
-174.31
(-0.59%)
KSE 30
19,739.37
16.66
(0.08%)
KMI 30
68,804.99
-145.10
(-0.21%)
KMI ALL
19,893.39
-95.75
(-0.48%)
Ferozsons Laboratories Limited
PHARMACEUTICALS
Rs.226.35
11.60
(5.40%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Wed, Jan 22, 2020 4:13 PM
REG
FUT
ODL
Open
217.00
High
226.56
Low
215.00
Volume
311,300
CIRCUIT BREAKER
202.94 — 226.56
DAY RANGE
215.00 — 226.56
52-WEEK RANGE
86.87 — 236.00
Ask Price
226.35
Ask Volume
1,800
Bid Price
0.00
Bid Volume
0
LDCP
214.75
VAR
12.65
HAIRCUT
16.50
P/E Ratio (TTM)
25.35
1-Year Change *
26.39%
YTD Change *
7.98%
Open
218.99
High
222.50
Low
218.99
Close
224.98
Change
2.86%
LDCP
214.75
Volume
229
Total Trades
10
CIRCUIT BREAKER
193.28 — 236.22
DAY RANGE
218.99 — 222.50
Ask Price
226.65
Ask Volume
50
Bid Price
218.00
Bid Volume
99
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Ferozsons Laboratories Limited was incorporated as a private limited company on 28 January 1954 and was subsequently converted into a public limited company. The Company is primarily engaged in the imports, manufacture and sale of pharmaceuticals products and medical devices.

KEY PEOPLE
Mrs. Akhter Khalid WaheedChairman
Mr. Osman Khalid WaheedCEO
Mr. Syed Ghausuddin SaifCompany Secretary
ADDRESS

Ferozsons Laboratories Limited 197-A, The Mall Rawalpindi, Pakistan.

WEBSITE

www.ferozsons-labs.com

REGISTRAR

CorpTec Associates (Pvt.) Limited, 503-E, Johar Town, Lahore

AUDITOR

KPMG Taseer Hadi & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
6,832,791.46
Shares
30,186,841
Free Float
12,074,736
Free Float
40.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2019Transmission of Quarterly Report for the Period Ended 30-09-2019 View   PDF
Oct 25, 2019Financial Results for the Quarter Ended 2019-09-30 View   PDF
Oct 4, 2019Transmission of Annual Report for the Year Ended 30-06-2019 View   PDF
Sep 23, 2019Financial Results for the Year Ended 2019-06-30 View   PDF
Sep 23, 2019Financial Results for the Quarter Ended 2019-06-30 View   PDF
Apr 30, 2019Transmission of Quarterly Report for the Period Ended 31-03-2019 View   PDF
Apr 17, 2019Financial Results for the Quarter Ended 2019-03-31 View   PDF
Feb 28, 2019Transmission of Quarterly Report for the Period Ended 2018-12-31 View   PDF
Feb 25, 2019Financial Result Results for the Quarter Ended 2018-12-31 View   PDF
Oct 30, 2018Transmission of Quarterly Report for the Period Ended 2018-09-30 View   PDF
DateTitleDocument
Oct 31, 2019Certified Copies of Resolutions passed in the Annual General Meeting View   PDF
Oct 18, 2019Board Meeting View   
Oct 2, 2019Notice of Annual General Meeting View   PDF
Sep 13, 2019Board Meeting View   
Apr 11, 2019Board Meeting View   
Apr 10, 2019Board Meeting View   
Feb 15, 2019Board Meeting View   
Oct 19, 2018Board Meeting View   
Oct 5, 2018Notice of Annual General Meeting View   PDF
Sep 18, 2018Board Meeting View   
DateTitleDocument
Jan 17, 2020Material Information View   
Nov 18, 2019Corporate Briefing Session (CBS) View   PDF
Nov 13, 2019Credit of Final Cash Dividend View   
Jul 26, 2019Change of Chief Financial Officer View   
Mar 15, 2019Credit of Interim Cash Dividend View   
Feb 28, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Feb 26, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Nov 9, 2018Credit of Final Cash Dividend View   
Sep 6, 2018Change in Beneficial Ownership of Director View   
Oct 25, 2017Dispatch of Final Dividend Warrants View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2019201820172016
Sales5,180,8044,459,3234,311,44210,186,496
Profit after Taxation251,04695,406393,6652,104,486
EPS8.323.1613.0469.72
Q1 2020Q3 2019Q2 2019Q1 2019
Sales1,188,8281,242,0281,297,4061,046,141
Profit after Taxation83,00213,13276,95264,617
EPS2.750.432.552.14
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2019201820172016
Gross Profit Margin (%)39.4935.2041.2140.34
Net Profit Margin (%)4.852.149.1320.66
EPS Growth (%)163.29(75.77)(81.30)181.13
PEG0.08(0.81)(0.36)0.08

Payouts

DateFinancial ResultsDetailsBook Closure
September 23, 2019 2:47 PM30/06/2019(YR) 40%(F) (D) 18/10/2019 - 25/10/2019
February 25, 2019 12:50 PM31/12/2018(HYR) 20% (i) (D) 08/03/2019 - 14/03/2019
September 25, 2018 3:08 PM30/06/2018(YR) 20% (D) 20/10/2018 - 27/10/2018
August 30, 2017 3:38 PM30/06/2017(YR) 40% (D) M /10/2017 - 18/10/2017
January 30, 2017 3:47 PM31/12/2016(HYR) 30%(I) (D) 11/02/2017 - 19/02/2017
August 30, 2016 10:16 AM30/06/2016(YR) 120% (F) (D) 11/10/2016 - 20/10/2016
January 26, 2016 9:54 AM31/12/2015(HYR) 100%(I) (D) 20/02/2016 - 26/02/2016
August 31, 2015 9:51 AM30/06/2015(YR) 150% (D) 13/10/2015 - 19/10/2015
August 31, 2015 9:51 AM30/06/2015(YR) 150% (D) 13/10/2015 - 19/10/2015
February 16, 2015 3:52 PM31/12/2015(HYR) 40%(I) (D) 13/03/2015 - 20/03/2015

Financial Reports